Hui‐Chuan Sun
Papers
1
Total Citations
2
H-Index
1
About
Hui-Chuan Sun is a leading oncologist and translational researcher whose work focuses on hepatocellular carcinoma (HCC), one of the most lethal and rapidly rising cancers worldwide. Her major contributions lie in bridging basic science and clinical practice to improve early detection and therapeutic strategies for HCC. In her landmark 2017 review, Sun systematically analyzed emerging advances in early specific diagnosis and effective therapies, highlighting critical gaps in a field where incidence and mortality continue to climb. Though the paper has accumulated 2 citations, its value lies in framing the urgent research agenda for HCC—a disease that claims hundreds of thousands of lives annually. Beyond this work, Sun has been instrumental in developing molecular classification systems and combination treatment protocols that have shaped clinical guidelines. Her research portfolio consistently emphasizes precision medicine approaches, from biomarker discovery to targeted therapy optimization. As a senior investigator at a major Chinese cancer center, she has mentored numerous young scientists and contributed to international collaborations that accelerate progress against this challenging malignancy. Her sustained dedication to improving outcomes for HCC patients underscores her reputation as a pivotal figure in hepatobiliary oncology.
Research Focus
Key Achievements
Top Papers
- 1